Peck-Radosavljevic, Markus

Publishing since 1997 (Senior)

Has published 65 publications in 14 years

Number of publications published per year by Peck-Radosavljevic, Markus. (Source : PubMed)

Distribution of publications types for Peck-Radosavljevic, Markus. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Peck-Radosavljevic M, Greten TF, Lammer J, Rosmorduc O, Sangro B, Santoro A, Bolondi L. Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.  Eur J Gastroenterol Hepatol  2010;22;4  
•  He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T, Sieghart W, Peck-Radosavljevic M, Leffert HL, Karin M. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.  Cancer Cell  2010;17;3  
•  Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U, Schmidt HH, Spengler U, Wirth S, Kessler HH, Peck-Radosavljevic M, Ferenci P, Vogel W, Moradpour D, Heim M, Cornberg M, Protzer U, Manns MP, Fleig WE, Dollinger MM, Zeuzem S. [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]  Z Gastroenterol  2010;48;2  
•  Zulehner G, Mikula M, Schneller D, van Zijl F, Huber H, Sieghart W, Grasl-Kraupp B, Waldhör T, Peck-Radosavljevic M, Beug H, Mikulits W. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.  Am. J. Pathol.  2010;176;1  
•  Peck-Radosavljevic M. TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect health.  Liver Int.  2010;30;1  
•  Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck-Radosavljevic M. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.  Dig Liver Dis  2009;41;12  
•  Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.  J. Hepatol.  2009;51;5  
•  Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.  J. Viral Hepat.  2009  
•  Schmid M, Mittermaier C, Voller B, Fialka-Moser V, Gangl A, Peck-Radosavljevic M. Postural control in patients with liver cirrhosis: a posturographic study.  Eur J Gastroenterol Hepatol  2009;21;8  
•  Rautou PE, Angermayr B, Garcia-Pagan JC, Moucari R, Peck-Radosavljevic M, Raffa S, Bernuau J, Condat B, Levardon M, Yver C, Ducarme G, Luton D, Denninger MH, Valla D, Plessier A. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes.  J. Hepatol.  2009;51;1  

[ See timeline ] [ See all publications ]